Disaggregation Should Extend to Race and Ethnicity: The Missing Pieces in the SAGER Guidelines

Abstract

The SAGER recommendations on the inclusion of sex and gender as reportable variables in medical trials are a significant advancement. There is an oversight and failure to include race and ethnicity in medical research trials that has profound implications for the development of effective health care treatment. Previous orthopaedic studies have proven that different racial/ethnic population groups have differences that affect the epidemiology of injury and response to surgery. It is only by including and desegregating data from these diverse patient populations will results accurately reflect treatment outcomes.